Local peer-to-peer learning relationships are a critical part of the overall decision to try to adopt new medical innovations, but they are very challenging to identify. In this podcast, we discuss current best practices for identification of locally influential thought leaders and mapping their learning communities.
Trends to Watch in Patient-first Pharma Marketing
May 10th 2022As healthcare increasingly shifts to digital, new pharma marketing and patient engagement trends are emerging at the forefront of care. In this podcast, Phreesia Life Sciences and Pharmaceutical Executive discuss how technology is changing healthcare consumers’ expectations and helping to create more personalized experiences focused on connecting the right patients to the right content, care and resources.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Networks Matter – Peer-to-Peer Relationships
November 5th 2021Peer-to-peer learning relationships, such as Thought Leader Networks, are critically important for successful adoption of medical innovations. Learn how these networks, or the different types of “communities”, each play a unique and complementary role in the adoption process.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.